| Popis: |
Introduction Calcipotriol ointment (DAIVONEX) has been shown to be effective in the treatment of chronic plaque psoriasis. Aim: To evaluate the efficacy and safety of calcipotriol ointment (50 µg / g) in the treatment of chronic plaque psoriasis. Patients and Methods: A prospective, non-controlled, open clinical trial of calcipotriol ointment (50μg/g) was conducted in the department of Dermatology, Bahawal Victoria Hospital, Bahawalpur for one-year duration from July 2019 to July 2020. A total of 61 patients (39 male, 22 females, aged 18 to 76 years) with chronic plaque psoriasis were enrolled in an open-label, prospective study. 51 completed the study. Calcipotriol ointment was applied twice daily for up to 6 weeks to the lesion area, after a 2-week washout phase with liquid paraffin. Efficacy, as measured by the Psoriasis Severity Index (PASI), and safety were assessed at 2, 4 and 6 weeks. Results: The reduction in PASI was statistically highly significant at all visits. Mean PASI decreased from 10.47 to 2.18 over 6 weeks (p Conclusion: Topical application of 50 µg / g calcipotriol ointment was found to be effective and safe in the treatment of chronic plaque psoriasis. Key words: Calcipotriol (DAIVONEX), psoriasis treatment, PASI |
